Searched for
ZYDUS VACCINE
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Zydus to develop combination vaccine for shigellosis and typhoidZydus Lifesciences is set to develop a combination vaccine against shigellosis and typhoid with the Gates Foundation's support. The vaccine...
- Production ramp up delayed Zydus Cadila’s vaccine launch, roll out likely soonZydus had received an order from the government to supply 10 million doses of ZyCoV-D, the world's first plasmid DNA vaccine, at ₹265 per d...
- Zydus Cadila's shot to be soon part of vaccine driveTo begin with, seven states including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal will use the vaccine.
- Zydus Cadila's ZyCov-D shot to soon join other vaccines in India's Covid fightThe drug regulator had on August 20 given emergency use authorisation (EUA) to the three-dose Covid-19 vaccine, the first in India that can...
- Right pricing to hold the key for Zydus Cadila's vaccine launchZydus Cadila has the drug regulator's emergency use authorisation to administer its Covid vaccine, ZyCoV-D, in children aged 12-18 years. A...
- Zydus Cadila gets permission to conduct phase III trial for two-dose Covid vaccineThe drug regulator had approved Zydus’ vaccine on August 20 for emergency use in India.
- Zydus vaccine likely to cost Rs 300 a doseHealth secretary Rajesh Bhushan on Thursday had spoken about the pricing. "We are in conversation with the manufacturer. Since it is a thre...
- Zydus jab likely to cost more than Covishield, pricing to be out soonZydus Cadila's Covid vaccine, which is likely to be launched next month, may cost more than Covishield but will be comparable with those al...
- Government may earmark a part of Zydus vaccine for sick kidsThe drug regulator had last week approved ZyCov-D, the world’s first DNA-based vaccine against the novel coronavirus, for emergency use in ...
- Drug regulator okays Zydus Cadila's three-dose Covid vaccine, first in India to be given to kids above 12The Indian drug regulator has given emergency use authorisation (EUA) to Zydus Cadila's three-dose Covid-19 vaccine, the ministry of scienc...
- Zydus Cadila likely to get emergency use approval for its COVID vaccine this week: SourcesZydus Cadila last month had said that it has applied for emergency use authorisation (EUA) with the Indian Drug regulator for its three-dos...
- Zydus vaccine under close review, approval likely to get delayedZydus had applied for emergency use authorisation (EUA) for its vaccine on July 1, but it is yet to be taken up by the subject expert commi...
- The 2-billion Vaccine Question: How realistic are estimates and what's the current status?The Centre’s plan for 2 billion doses of Covid-19 vaccines by year-end depends on a massive ramp-up of production as well as flawless trial...
- Zydus Cadila to apply for Phase-3 trials in December, hopes to launch vaccine by MarchThe Ahmedabad-based drug maker will submit the results of its phase-2 trials next week, which "will ascertain the safety, dose and efficacy...
- Human trials of COVID-19 vaccine candidate important milestone for Atmanirbhar Bharat: DBTZydus Cadila's move to begin human trials of its indigenously developed vaccine candidate for COVID-19 is an important milestone for an 'At...
- Zydus Cadila buys Dutch firm Etna BiotechThe Ahmedabad-based pharma major Zydus Cadila on Tuesday said it has acquired Etna Biotech, a subsidiary of the Dutch biopharma company, Cr...
Load More
